Chronic Kidney Disease: Improving mortality rate through early diagnosis

Categories: Alliance News, Featured

Chronic Kidney Disease: Improving mortality rate through early diagnosis

Chronic kidney disease is exceedingly common, impacting as many as one in seven adults in the U.S. But many people do not know they have it. Left untreated it can lead to costly, invasive treatment or even death.

In early September, the Alliance pulled together experts to discuss the impact of this disease in Washington, and how early diagnosis and treatment can dramatically improve outcomes and cut health care costs.

The hour-long webinar touched on key themes including:

  • How Washington state performs when it relates to the diagnosis and early treatment of CKD with an emphasis on equity measures
  • The financial impact of CKD when proper early screening is not done
  • How an employer acted on improving the health trajectory for their members with CKD and created savings


Watch a recording of the event below:



Drew Oliveira, MD, MHA, the Alliance’s executive director shared key statistics about the impact of chronic kidney disease here in Washington State.

Jennifer Jackels, BSN, RN ​, Clinical Quality Improvement Manager ​at The Everett Clinic & The Polyclinic – part of Optum, shared insights into how her health care organization performed well in addressing care gaps for patients with chronic kidney disease.

Dr. Michael Shannon, Chief Medical Officer, MultiCare Connected Care​, and Medical Director, MultiCare Employee Health Plan, offered a view into how an employer with thousands of employees acted to improve health outcomes for those with chronic kidney disease, which in turn saved costs.

If you have any questions about the program or wish to learn more, please contact Denise Giambalvo, Director of Member Engagement and Business Strategy, at

The event was supported by Bayer.